Status:
UNKNOWN
A First in Human Evaluation of a Novel Approach to Painless Cardioversion (NAPC) in Patients With Atrial Fibrillation
Lead Sponsor:
MediCool Technologies
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
An assessment of the use of cold therapy to terminate atrial fibrillation.
Eligibility Criteria
Inclusion
- Subject must be ≥ 18 years or older
- Male of female
- Subject has documented paroxysmal, or persistent atrial fibrillation (AF) with a history of less than one-year duration
- Must be in AF at time of surgery, or inducible using manual or electrical stimulation
- Subject is willing and able to provide written informed consent
- Subject has a life expectancy of at least 1 year
Exclusion
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05324540
Start Date
April 1 2022
End Date
March 1 2023
Last Update
April 12 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.